Hand in hand: intrinsic and extrinsic drivers of aging and clonal hematopoiesis.

Document Type

Article

Publication Date

11-1-2020

Keywords

JMG, Aging, Animals, Antineoplastic Agents, Bone Marrow, Cellular Senescence, Chromatin, Clone Cells, DNA (Cytosine-5-)-Methyltransferases, DNA Damage, DNA Methylation, Feedback, Physiological, Female, Forecasting, Hematopoiesis, Hematopoietic Stem Cells, Humans, Inflammation, Male, Mice, Mutation, Myeloid Cells, Selection, Genetic, Stem Cell Niche

JAX Source

Exp Hematol 2020 Nov; 91:1-9

Volume

91

First Page

1

Last Page

9

ISSN

1873-2399

PMID

32991978

DOI

https://doi.org/10.1016/j.exphem.2020.09.197

Grant

DK118072, AG069010, DK112947, CA184851, HD007065

Abstract

Over the past 25 years, the importance of hematopoietic stem cell (HSC) aging in overall hematopoietic and immune system health span has been appreciated. Much work has been done in model organisms to understand the intrinsic dysregulation that occurs in HSCs during aging, with the goal of identifying modifiable mechanisms that represent the proverbial "fountain of youth." Much more recently, the discovery of somatic mutations that are found to provide a selective advantage to HSCs and accumulate in the hematopoietic system during aging, termed clonal hematopoiesis (CH), inspires revisiting many of these previously defined drivers of HSC aging in the context of these somatic mutations. To truly understand these processes and develop a holistic picture of HSC aging, ongoing and future studies must include investigation of the critical changes that occur in the HSC niche or bone marrow microenvironment with aging, as increasing evidence supports that these HSC-extrinsic alterations provide necessary inflammation, signaling pathway activation or repression, and other selective pressures to favor HSC aging-associated phenotypes and CH. Here, we provide our perspectives based on the past 8 years of our own laboratory's investigations into these mechanisms and chart a path for integrative studies that, in our opinion, will provide an ideal opportunity to discover HSC and hematopoietic health span-extending interventions. This path includes examining when and how aging-associated HSC-intrinsic and HSC-extrinsic changes accumulate over time in different individuals and developing new models to track and test relevant HSC-extrinsic changes, complementary to innovative HSC lineage tracing systems that have recently been developed.

Comments

We are grateful to Taneli Helenius for critical input and editing of this article and Jane Cha for original and adapted artwork. We thank all current and past members of the Trowbridge laboratory for their contributions

Link to Full Text

Share

COinS